What "healthcare AI company" actually covers
Search for "top healthcare AI companies" and you'll get everything from multibillion-dollar enterprise revenue cycle platforms to two-person startups selling a single Chrome extension. They're all technically accurate answers to the search, and almost none of them are useful to compare directly, because they aren't competing for the same buyer.
For denial management specifically — the part of revenue cycle where a claim gets rejected and someone has to decide whether and how to fight it — the market breaks into four real categories. Knowing which one you're shopping in matters more than any individual company's marketing.
The four categories
Enterprise RCM platforms
Full revenue-cycle suites — scheduling, eligibility, billing, and denials in one system. Built for hospital systems with dedicated IT and implementation teams. Denial handling is one module among many, not the whole product.
Point tools & clearinghouse add-ons
Narrow features bolted onto an existing clearinghouse or billing system — usually claim scrubbing or basic denial categorization. Cheap and fast to turn on, but shallow: they flag a denial, they don't research or draft the appeal.
Human-in-the-loop specialists
Built specifically for denial appeals: policy-specific research, an AI-drafted appeal letter citing the actual payer rule, and a person on staff who reviews and approves before anything is filed. Depth without a platform migration.
In-house builds
Larger systems or billing companies with their own engineering teams sometimes build denial-scoring tools internally, usually on top of their EHR/RCM data warehouse. Powerful if you have the team to maintain it indefinitely.
Enterprise platforms genuinely suit hospital systems — that's not a knock, it's the honest boundary. A large health system needs one system of record across scheduling, billing, and denials, with the implementation bandwidth to run a multi-year rollout. That's outside our own market anyway: Vellix AI builds for medical billing companies and small-to-mid independent providers, not hospital systems, so saying enterprise platforms fit hospitals well costs us nothing.
What to check before you evaluate any of them
| Check | Why it matters |
|---|---|
| Policy-specific research | A generic "resubmit" recommendation isn't an appeal. Does the tool cite the payer's actual coverage policy, not just a denial reason code? |
| Human sign-off | Nothing should file automatically. A person on your team should review and approve every appeal before it reaches a payer. |
| Audit trail | Can you see why the tool recommended what it recommended, after the fact? Reasoning that isn't reviewable isn't trustworthy. |
| Fit for your size | An enterprise platform sized for a 400-bed hospital will cost and implement like one, regardless of how few denials you actually process. |
| PHI handling | A Business Associate Agreement should be signed before any patient data is exchanged — not after, and not implied. |
The reason this category exists at all: a federal audit published in June 2026 found the largest Medicare Advantage plans denying long-term care hospital and rehab stays at 51–80%, and when skilled nursing facility denials were actually appealed, 95% got overturned. Yet only about one-fifth of denied SNF requests were appealed at all (~2,400 of 13,500 denials, HHS-OIG June 2026) — largely because appealing takes time most billing teams don't have, not because the cases are weak. That gap between "winnable" and "actually appealed" is the whole market.
Where DenialIQ fits
DenialIQ is a human-in-the-loop specialist, built for medical billing companies and small-to-mid independent providers — practices, clinics, FQHCs, and community/behavioral health organizations.
It checks a payer's specific policy against the claim, drafts a citation-backed appeal letter, and your staff review and approve every filing before it goes anywhere. We are not built or priced for large multi-hospital health systems, and we're not going to pretend otherwise to make the pitch bigger.